Clinical Trial Update: Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 in Japanese Postmenopausal Women

View source ↗

Summary

This clinical trial update reports on the safety, tolerability, pharmacokinetics and pharmacodynamics of PRA-027 in Japanese postmenopausal women with uterine f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• PRA-027

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Uterine Leiomyomata (Fibroids) | Status: COMPLETED